STIM Stock Summary and Trading Ideas (Neuronetics | NASDAQ:STIM)

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

What symbol and exchange does Neuronetics shares trade?

Neuronetics trades on the NASDAQ stock market under the symbol STIM.

What is Neuronetics stock price doing today?

As of July 21, 2026, STIM stock price declined to $1.88 with 2,757,957 million shares trading.

What is Neuronetics's Beta?

STIM has a beta of 2.39, meaning it tends to be more sensitive to market movements. STIM has a correlation of 0.08 to the broad based SPY ETF.

How much is Neuronetics worth?

STIM has a market cap of $130.83 million. This is considered a Micro Cap stock.

How much money does Neuronetics make?

Last quarter Neuronetics reported $34 million in Revenue and -$.16 earnings per share. This beat revenue expectation by $257,600 and exceeded earnings estimates by $.01.

What is the highest and lowest price Neuronetics traded in the last 3 year period?

In the last 3 years, STIM traded as high as $5.92 and as low as $.52.

What are the top ETFs holding Neuronetics?

The top ETF exchange traded funds that STIM belongs to (by Net Assets): PSIL, VTI, VXF, IWC, QQQS.

Is Neuronetics (STIM) a good investment?

STIM has underperformed the market in the last year with a return of -48.6%, while SPY returned +20.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in STIM shares. However, STIM has outperformed the market in the last 3 month and 2 week periods, returning +19.0% and +20.5%, while SPY returned +5.9% and -0.4%, respectively. This indicates STIM has been having a stronger performance recently.

What are the support and resistance levels for Neuronetics (STIM)?

STIM support price is $1.86 and resistance is $2.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that STIM shares will trade within this expected range on the day.